Jacob P. Lalezari - Oct 28, 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Chief Executive Officer
Signature
/s/ Tyler Blok, attorney-in-fact for Jacob P. Lalezari
Stock symbol
CYDY
Transactions as of
Oct 28, 2024
Transactions value $
$0
Form type
4
Date filed
10/30/2024, 09:47 PM
Previous filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +3M $0.00 3M Oct 28, 2024 Common Stock 3M $0.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended.
F2 250,000 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028.